Abstract
The limited effectiveness of current treatments for neurodevelopmental disorders, often hindered by the blood-brain barrier (BBB) and CNS complexity, makes gene therapy a challenge. Autism Spectrum Disorders (ASD) has been associated with various mutations in the DEAF1 gene, including missense, frameshift and indels variants. These mutations give rise to two distinct intellectual disabili…